Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Next-generation CAR T therapy offers hope but faces clinical challenges

A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled "CAR-T therapy: Trailblazing CAR(ing) in cancer treatment."

25 Feb 2026

Phase 2 clinical trial tests LMP744 for the treatment of first-time recurrent glioblastoma

Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent glioblastoma patients.

25 Feb 2026

Unexpected behavior observed during interactions between immune cells and dying cells

Over the years, cell biology has built a detailed picture of how cells compartmentalize their internal functions. Central to this organization is the nucleus, which houses the genetic material and is separated from the cytoplasm by a robust nuclear envelope.

25 Feb 2026

Element Biosciences introduces VITARI™, redefining what high-throughput sequencing makes possible

Element Biosciences Inc. today announced VITARI, the first ever high-throughput benchtop sequencing system capable of delivering a high-quality whole genome at $100.

25 Feb 2026

Democrats decry meager medical care for detainees in funding fight

Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration detention center in California's Mojave Desert.

25 Feb 2026

Mental health struggles in first year of cancer care predict worse outcomes

This study reveals a strong association between early mental health disorders in cancer patients and increased all-cause mortality, highlighting care needs.

25 Feb 2026

Study identifies mitochondrial circular RNAs in aging and senescence

A new research paper was published in Volume 18 of Aging-US on February 10, 2026, titled "Aging-associated mitochondrial circular RNAs."

24 Feb 2026

Throwing cancer-driving proteins in the cellular trash

When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them - throw them in the cellular trash.

24 Feb 2026

Bruker advances Functional Proteomics 2.0 with timsOmni™ mass spectrometry proteoform analysis for deeper insights into disease biology

Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni™ mass spectrometer to enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants.

From Bruker Daltonics 24 Feb 2026

Assessing long-term cognitive risks in ependymoma survivors

A study led by St. Jude Children's Research Hospital assessed cognitive and communication abilities in children treated for the brain tumor ependymoma to understand the impact of treatment better. They found that radiation was a significant contributor to hearing loss, a risk directly linked to cognitive health.

23 Feb 2026

New EANM award supports alpha radioligand therapy research

Applications are now open for the 2026 EANM Young Scientist Network Award. This new research award, supported by Advanced Accelerator Applications (a Novartis company), aims to accelerate innovative research in alpha radioligand therapy (α-RLT) in prostate cancer.

23 Feb 2026

Ochsner MD Anderson Cancer Center delivers Louisiana’s first TIL therapy for melanoma

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to provide an adult patient with tumor-infiltrating lymphocytes (TIL) therapy for advanced melanoma.

23 Feb 2026

Study finds microplastics in most prostate tumors

Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds.

23 Feb 2026

Distinct gut toxicity patterns emerge with targeted cancer treatments

A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled "Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection."

20 Feb 2026

Stereotactic radiation improves quality of life in patients with brain metastases

In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day to day function when compared with whole brain radiation

19 Feb 2026

Study reveals long-term health risks after chemotherapy for testicular cancer

A large, multi-center study recently published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy regimens used to treat testicular cancer, highlighting differences in renal function, cardiovascular risk, and the overall burden of chronic health conditions among survivors.

19 Feb 2026

Blood test shows promise in forecasting outcomes for germ cell tumors

Previous
1
...
27
28
29
30
31
32
33
...
1248
Next

Oncology News and Research

Further Reading

Next-generation CAR T therapy offers hope but faces clinical challenges

Phase 2 clinical trial tests LMP744 for the treatment of first-time recurrent glioblastoma

Unexpected behavior observed during interactions between immune cells and dying cells

Element Biosciences introduces VITARI™, redefining what high-throughput sequencing makes possible

Democrats decry meager medical care for detainees in funding fight

Mental health struggles in first year of cancer care predict worse outcomes

Study identifies mitochondrial circular RNAs in aging and senescence

Throwing cancer-driving proteins in the cellular trash

Bruker advances Functional Proteomics 2.0 with timsOmni™ mass spectrometry proteoform analysis for deeper insights into disease biology

Assessing long-term cognitive risks in ependymoma survivors

New EANM award supports alpha radioligand therapy research

Ochsner MD Anderson Cancer Center delivers Louisiana’s first TIL therapy for melanoma

Study finds microplastics in most prostate tumors

Distinct gut toxicity patterns emerge with targeted cancer treatments

Stereotactic radiation improves quality of life in patients with brain metastases

Study reveals long-term health risks after chemotherapy for testicular cancer

Blood test shows promise in forecasting outcomes for germ cell tumors

Changes in lymphatic vessels can help identify aggressive oral cancer at an early stage

New approach better predicts chemotherapy response in patients with triple-negative breast cancer

M-PACT sets new standard for pediatric brain tumor diagnostics, treatment monitoring

Your guide to microplate readers for cancer research eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News